Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Plasma Cell × daratumumab × Clear all

Sponsor

Conditions

Multiple Myeloma 35 Leukemia, Myeloid, Acute 4 Recurrence 3 Waldenstrom Macroglobulinemia 2 Immunoglobulin Light-chain Amyloidosis 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hypergammaglobulinemia 1 Hodgkin Disease 1

Interventions

Melphalan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Peripheral Blood Stem Cell Transplantation 3 Mycophenolic Acid 3 Cyclophosphamide 3 Tacrolimus 2 pomalidomide 1 ixazomib 1 elotuzumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carmustine, poliferprosan 20 drug combination 1 auricularum 1 Stem Cell Transplantation 1 Sirolimus 1 Panobinostat 1 Lenalidomide 1 Gemcitabine 1 Etoposide 1 Dexamethasone 1 Cytarabine 1 Carmustine 1 Calcium Dobesilate 1 Busulfan 1 Bortezomib 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡